Metabolic basis of primary hypercholesterolemia
- PMID: 2060088
- DOI: 10.1161/01.cir.84.1.118
Metabolic basis of primary hypercholesterolemia
Abstract
Background: Hypercholesterolemia is a well-established risk factor for coronary heart disease. However, the mechanisms underlying hypercholesterolemia, elevated low density lipoprotein (LDL) in particular, are not well understood. To determine these mechanisms, we studied LDL kinetics in a group of men with primary hypercholesterolemia.
Methods and results: LDL kinetics in 134 middle-aged men with high-risk levels of LDL cholesterol (more than 160 mg/dl) were compared with kinetics in 16 men with borderline high-risk levels of LDL cholesterol (120-159 mg/dl) and 14 men with heterozygous familial hypercholesterolemia (FH). Patients with primary hypercholesterolemia (non-FH) were further divided into moderate hypercholesterolemia (LDL cholesterol, 160-210 mg/dl; n = 108) and severe hypercholesterolemia groups (LDL cholesterol, more than 210 mg/dl; n = 26). Four factors contributed to increasing LDL cholesterol concentrations above the borderline range to moderately elevated levels: 37 patients had no increase in LDL apolipoprotein (apo) B levels but had abnormally high LDL cholesterol-to-apo B ratios; 14 patients had very low fractional catabolic rates (FCRs) for LDL, similar to FH patients; 35 patients had FCRs for LDL in the borderline range but high production rates for LDL; and 22 patients had a high flux of LDL (high production rates and high FCRs). In general, patients with severe hypercholesterolemia resembled those with moderate LDL elevations, except that their LDL particles were enriched with cholesterol.
Conclusions: Data from the present study reveal that there are several distinct patterns of LDL metabolism responsible for primary hypercholesterolemia. These patterns can serve as the basis for further investigation to determine the molecular defects responsible for each pattern.
Similar articles
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
-
Low density lipoprotein kinetics in a family having defective low density lipoprotein receptors in which hypercholesterolemia is suppressed.Arterioscler Thromb. 1991 May-Jun;11(3):578-85. doi: 10.1161/01.atv.11.3.578. Arterioscler Thromb. 1991. PMID: 2029498
-
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.J Am Coll Cardiol. 2013 Dec 10;62(23):2178-84. doi: 10.1016/j.jacc.2013.07.081. Epub 2013 Sep 4. J Am Coll Cardiol. 2013. PMID: 24013058 Clinical Trial.
-
Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin.JAMA. 1994 Feb 9;271(6):453-9. doi: 10.1001/jama.271.6.453. JAMA. 1994. PMID: 8295321 Clinical Trial.
-
Mechanisms of primary hypercholesterolemia in humans.Am Heart J. 1987 Feb;113(2 Pt 2):493-502. doi: 10.1016/0002-8703(87)90620-x. Am Heart J. 1987. PMID: 3544763 Review.
Cited by
-
Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.Biochem J. 2002 Sep 1;366(Pt 2):531-9. doi: 10.1042/BJ20020046. Biochem J. 2002. PMID: 12030847 Free PMC article.
-
Statins: definitive translational research.Mol Med. 2014 Dec 16;20 Suppl 1(Suppl 1):S20-3. doi: 10.2119/molmed.2014.00194. Mol Med. 2014. PMID: 25549229 Free PMC article. Review. No abstract available.
-
Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.Lipids. 1997 Aug;32(8):811-23. doi: 10.1007/s11745-997-0104-2. Lipids. 1997. PMID: 9270972
-
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemia.Clin Investig. 1993 Nov;71(11):939-46. doi: 10.1007/BF00185608. Clin Investig. 1993. PMID: 8312689 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous